William Fong

Partner, Hong Kong SAR



William Fong is a partner in the Mergers & Acquisitions and Private Equity Practice, based in Hong Kong.

William has over 10 years of experience advising private equity sponsors and their portfolio companies as well as public and private companies on domestic and cross-border acquisitions and divestitures.

Bars and Courts
Hong Kong
University of Hong Kong
University of Warwick


His experience* includes representing:

  • Creative Artists Agency, LLC (CAA), a leading global entertainment and sports agency, in its acquisition of the business of CAA-GBG, one of the world's leading brand management agencies.
  • CAA China LLC, a joint venture subsidiary of CAA, in the acquisition of Momentum Sports, a marketing, brand consulting and athlete representation company in the PRC.
  • The Special Committee formed by the Board of Directors of Cellular Biomedicine Group, Inc. (Nasdaq: CBMG), a US-headquartered biopharmaceutical company engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases with operations in Greater China, on its going private sale to a consortium led by the CEO of CBMG, together with certain members of CBMG management, CBMG stockholders and financial sponsors.
  • CMC Capital Partners in multiple private equity transactions, acquisitions and divestitures involving a number of media and entertainment targets, including the sale of its equity interests in CAA US, in connection with TPG's sale of its controlling equity interests in CAA US to Artemis for US$7 billion; and multiple other investments in China, including in Bilibili, El.eme, WeRide, etc.
  • EQT Partners and its portfolio company GPA Global, a leader in premium packaging, sustainable packaging and display solutions based in China, on GPA Global’s bolt-on acquisition of Hub Folding Box, a printing and packaging company in the US.
  • GDS Holdings Limited, through its wholly-owned subsidiary DigitalLand Holdings Limited, on the US$587 million Series A equity financing of its international business.
  • Goldman Sachs (Asia) LLC in multiple investments in Asia-Pacific.
  • Icon Group, a portfolio company of Goldman Sachs Principal Investment Area, in its acquisition of Hong Kong-based oncology clinic SunTech Medical Group.
  • Various investment funds as the sellers of an indirect interest in the Khoemacau copper mine to MMG Limited for an enterprise value of US$1.875 billion.

*Includes experience prior to working in White & Case

Awards and Recognition

Recognized as a 'Rising Star' in Private Equity (including Venture Capital) by IFLR Rising Stars Asia-Pacific Awards 2022

Recognized as a 'Rising Star' by China Business Law Journal 2022

Recognized as a 'Next Generation Partner' in Private Equity by Legal 500 Asia-Pacific 2022-2023

Recognized as a 'Up and Coming' in Private Equity by Chambers Greater China 2023